How to buy Phibro Animal Health Corporation stock

Phibro Animal Health Corporation is a drug manufacturers-specialty & generic business based in the US. Phibro Animal Health Corporation shares (PAHC) are listed on the NASDAQ and all prices are listed in US Dollars. Phibro Animal Health Corporation employs 1,700 staff and has a trailing 12-month revenue of around 0.00.

Phibro Animal Health Corporation share price

Use our graph to track the performance of PAHC stocks over time.

Phibro Animal Health Corporation shares at a glance

• Key figures

Information last updated 2021-04-23.

52-week range	$16.08 - $27.89
50-day moving average	$24.47
200-day moving average	$20.92
Wall St. target price	$20.00
PE ratio	22.9083
Dividend yield	$0.48 (1.89%)
Earnings per share (TTM)	$1.09

Buy Phibro Animal Health Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Phibro Animal Health Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Phibro Animal Health Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Phibro Animal Health Corporation under- or over-valued?

Valuing Phibro Animal Health Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Phibro Animal Health Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Phibro Animal Health Corporation's P/E ratio

Phibro Animal Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, Phibro Animal Health Corporation shares trade at around 23x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Phibro Animal Health Corporation's PEG ratio

Phibro Animal Health Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7831. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Phibro Animal Health Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Phibro Animal Health Corporation's EBITDA

Phibro Animal Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $103.5 million.

The EBITDA is a measure of a Phibro Animal Health Corporation's overall financial performance and is widely used to measure a its profitability.

Phibro Animal Health Corporation financials

Revenue TTM	$798 million
Operating margin TTM	9.03%
Gross profit TTM	$257.2 million
Return on assets TTM	5.66%
Return on equity TTM	20.54%
Profit margin	5.55%
Book value	$5.27
Market capitalisation	$1 billion

TTM: trailing 12 months

Shorting Phibro Animal Health Corporation shares

There are currently 1.4 million Phibro Animal Health Corporation shares held short by investors – that's known as Phibro Animal Health Corporation's "short interest". This figure is 2.6% up from 1.3 million last month.

There are a few different ways that this level of interest in shorting Phibro Animal Health Corporation shares can be evaluated.

Phibro Animal Health Corporation's "short interest ratio" (SIR)

Phibro Animal Health Corporation's "short interest ratio" (SIR) is the quantity of Phibro Animal Health Corporation shares currently shorted divided by the average quantity of Phibro Animal Health Corporation shares traded daily (recently around 159597.64150943). Phibro Animal Health Corporation's SIR currently stands at 8.48. In other words for every 100,000 Phibro Animal Health Corporation shares traded daily on the market, roughly 8480 shares are currently held short.

However Phibro Animal Health Corporation's short interest can also be evaluated against the total number of Phibro Animal Health Corporation shares, or, against the total number of tradable Phibro Animal Health Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Phibro Animal Health Corporation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Phibro Animal Health Corporation shares in existence, roughly 30 shares are currently held short) or 0.0929% of the tradable shares (for every 100,000 tradable Phibro Animal Health Corporation shares, roughly 93 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Phibro Animal Health Corporation.

Find out more about how you can short Phibro Animal Health Corporation stock.

Phibro Animal Health Corporation share dividends

Dividend payout ratio: 41.38% of net profits

Recently Phibro Animal Health Corporation has paid out, on average, around 41.38% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.92% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Phibro Animal Health Corporation shareholders could enjoy a 1.92% return on their shares, in the form of dividend payments. In Phibro Animal Health Corporation's case, that would currently equate to about $0.48 per share.

While Phibro Animal Health Corporation's payout ratio might seem fairly standard, it's worth remembering that Phibro Animal Health Corporation may be investing much of the rest of its net profits in future growth.

Phibro Animal Health Corporation's most recent dividend payout was on 23 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 1 March 2021 (the "ex-dividend date").

Phibro Animal Health Corporation share price volatility

Over the last 12 months, Phibro Animal Health Corporation's shares have ranged in value from as little as $16.0804 up to $27.888. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Phibro Animal Health Corporation's is 0.5621. This would suggest that Phibro Animal Health Corporation's shares are less volatile than average (for this exchange).

Phibro Animal Health Corporation overview

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors.

Frequently asked questions

• What percentage of Phibro Animal Health Corporation is owned by insiders or institutions?

  Currently 0.397% of Phibro Animal Health Corporation shares are held by insiders and 107.798% by institutions.

• How many people work for Phibro Animal Health Corporation?

  Latest data suggests 1,700 work at Phibro Animal Health Corporation.

• When does the fiscal year end for Phibro Animal Health Corporation?

  Phibro Animal Health Corporation's fiscal year ends in June.

• Where is Phibro Animal Health Corporation based?

  Phibro Animal Health Corporation's address is: Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712

• What is Phibro Animal Health Corporation's ISIN number?

  Phibro Animal Health Corporation's international securities identification number is: US71742Q1067

• What is Phibro Animal Health Corporation's CUSIP number?

  Phibro Animal Health Corporation's Committee on Uniform Securities Identification Procedures number is: 71742Q106